99Tcm标记的混配放射性药物研究进展

Development of 99Tcm Labelled Mixed-Ligand Complexes

  • 摘要: 99Tcm标记的混配放射性药物是近年来在核医学领域中新兴的一类显像剂。本文介绍了“3+1”型、“4+1”型、“3+1+1”型、”“4+1+1”型和“2+2”型混配放射性药物的化学结构、生物分布及其优缺点。这几种类型的混配药物中,优以“2+2”型混配药物的化学、生物学特性为好,更具有好的应用前景

     

    Abstract: Recently, mixed-ligand technetium complexes are the novel tracers in nuclear medicine. Some 99Tcm complexes with different ligands were viewed,which include “3+1”,”4+1”,”3+1+1”,”4+1+1”and “2+2”, and their chemical properties, biodistribution and their limits were also discussed. Amone these ligands,the type “2+2” has the best characteristic of chemical and biology, and shows potential application values.

     

/

返回文章
返回